← Eichor
Study identifier: NCT07533890 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Fecal Microbiome Signature of Multi-Strain Probiotics Supplementation in Children and Adolescents With Inflammatory Bowel Disease

Condition: Inflamatory Bowel Disease  ·  Sponsor: Insel Gruppe AG, University Hospital Bern

PhaseNA
Planned participants40
Who can joinAll sexes, 5 Years to 18 Years
Healthy volunteersNo

About this study

In this study the intestinal microbiome and metabolic profiles of patients with inflammatory bowel disease will be determined upon probiotic intervention.

This description comes directly from the study's public registry record.

Talk to the study team

Christiane Sokollik, Prof  ·  +41 31 632 21 11  ·  christiane.sokollik@insel.ch

Always discuss trial participation with your own doctor first.

Locations (1)

Inselspital, Universitätsspital Bern KinderklinikBern, SwitzerlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07533890